CEACAM7 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM7 monoclonal antibodies for investigating CEACAM7 protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM7, a member of the carcinoembryonic antigen (CEA) family, plays a significant role in cell adhesion and immune response modulation. CEACAM7 is primarily expressed in the gastrointestinal tract and has been implicated in various physiological and pathological processes. Research has shown CEACAM7's involvement in tumor progression and metastasis. Understanding CEACAM7 function continues to be crucial for developing targeted therapies and diagnostic tools in cancer research. Investigating CEACAM7 expression patterns can provide valuable insights into disease mechanisms and potential therapeutic targets. Advanced research tools from Santa Cruz Biotechnology enable scientists to make meaningful contributions to cancer biology and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CEACAM7 and its role in human health and disease.